• 1. Merging cobalt and photoredox catalysis for the C8–H alkoxylation of 1-naphthylamine derivatives with alcohols
  Zhaoliang Xu,Yu Hu,Lei Wang,Mingli Sun,Pinhua Li Org. Biomol. Chem. 2021 19 10112
• 2. Co-crystals of diflunisal and isomeric pyridinecarboxamides – a thermodynamics and crystal engineering contribution
  António O. L. évora,Ricardo A. E. Castro,Teresa M. R. Maria,M. Ramos Silva,J. H. ter Horst,Jo?o Canotilho,M. Ermelinda S. Eusébio CrystEngComm 2016 18 4749
• 3. Coordination-driven self-assembly of thiocyanate complexes of Co(ii), Ni(ii) and Cu(ii) with picolinamide: a structural and DFT study
  Marijana ?akovi?,Diogo Vila-Vi?osa,Maria José Calhorda,Zora Popovi? CrystEngComm 2011 13 5863
• 4. Investigation of dioxygen activation by copper(ii)–iminate/aminate complexes
  Michael G. Papanikolaou,Sofia Hadjithoma,Dimitra S. Chatzikypraiou,Dionysios Papaioannou,Chryssoula Drouza,Athanassios C. Tsipis,Haralampos N. Miras,Anastasios D. Keramidas,Themistoklis A. Kabanos Dalton Trans. 2018 47 16242
• 5. Can self-assembly of copper(ii) picolinamide building blocks be controlled?
  Marijana ?akovi?,Diogo Vila-Vi?osa,Nuno A. G. Bandeira,Maria José Calhorda,Bojan Kozlev?ar,Zvonko Jagli?i?,Zora Popovi? CrystEngComm 2013 15 8074

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxamides
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxamides

Introduction to Picolinamide (CAS No. 1452-77-3)

Picolinamide, chemically identified by the CAS No. 1452-77-3, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical research and development. This compound, belonging to the amide class, exhibits a unique structural framework that makes it a versatile intermediate in synthesizing various bioactive molecules. The Picolinamide structure consists of a pyridine ring substituted with an amide functional group, which contributes to its diverse chemical reactivity and biological potential.

Recent advancements in medicinal chemistry have highlighted the Picolinamide as a promising scaffold for developing novel therapeutic agents. Its ability to interact with biological targets at the molecular level has been explored in several preclinical studies. One of the most intriguing aspects of Picolinamide is its role in modulating enzymatic activities and signaling pathways associated with various diseases, including inflammation, neurodegeneration, and metabolic disorders.

The pharmacological profile of Picolinamide has been extensively studied in vitro and in vivo. Research indicates that this compound can exhibit potent anti-inflammatory properties by inhibiting key pro-inflammatory cytokines and enzymes. For instance, studies have demonstrated that derivatives of Picolinamide can suppress the production of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), which are critical mediators of inflammation.

In addition to its anti-inflammatory effects, Picolinamide has shown potential in neuroprotective applications. Emerging evidence suggests that this compound can cross the blood-brain barrier and exert neuroprotective effects against oxidative stress and neurotoxicity. This makes it a valuable candidate for developing treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's disease. The ability of Picolinamide to interact with specific neurotransmitter receptors and ion channels has also been explored, further enhancing its therapeutic potential.

The synthetic chemistry of Picolinamide has been optimized to produce various derivatives with enhanced biological activity. Researchers have developed efficient synthetic routes that allow for the introduction of different functional groups into the pyridine ring, thereby tailoring the pharmacological properties of the compound. These derivatives have been tested in multiple disease models, demonstrating promising results in reducing disease progression and improving symptoms.

The safety profile of Picolinamide has also been evaluated through comprehensive toxicological studies. Preliminary findings suggest that this compound is well-tolerated at therapeutic doses, with minimal side effects observed in animal models. However, further clinical trials are necessary to confirm its safety and efficacy in human populations. The biodegradability and environmental impact of Picolinamide have also been assessed, ensuring that its use does not pose significant environmental risks.

The future direction of research on Picotinamide (CAS No. 1452-77-3) is likely to focus on developing more targeted therapies by combining it with other pharmacological agents or exploring its use in combination regimens. The integration of computational modeling and high-throughput screening techniques will aid in identifying new derivatives with improved pharmacokinetic properties and reduced toxicity.

In conclusion, Picolinamide (CAS No. 1452-77-3) represents a significant advancement in pharmaceutical research due to its versatile chemical structure and promising biological activities. Its potential applications in treating inflammatory diseases, neurodegenerative disorders, and other conditions make it a valuable compound for further exploration. As research continues to uncover new therapeutic uses for this molecule, it is expected to play an increasingly important role in the development of novel treatments for human diseases.

• 94413-68-0(6-(aminomethyl)pyridine-2-carboxamide)
• 1436-44-8(Isoquinoline-1-carboxylic acid amide)
• 50458-77-0(Isoquinoline-3-carboxamide)
• 20970-77-8(5-methylpyridine-2-carboxamide)
• 917925-74-7(2-Pyridinecarboxamide, hydrate (1:1))
• 4551-72-8(1H-Pyrrole-2-carboxamide)
• 4663-97-2(2,6-Pyridinedicarboxamide)
• 52392-49-1(Pyridinecarboxamide)
• 72693-02-8(2-Carbamoyl-4,6-dimethylpyridine)
• 719278-42-9(1H-Pyrrole-2,5-dicarboxamide)